申请人:Bayer Aktiengesellschaft
公开号:US05380851A1
公开(公告)日:1995-01-10
The present invention relates to new 2-amino-5-cyano-4-quinoline-1,4-dihydropyridines, processes for their preparation and their use in medicaments, in particular in agents for the treatment of cardiovascular diseases.
本发明涉及新的2-氨基-5-氰基-4-喹啉-1,4-二氢吡啶,其制备方法以及它们在药物中的应用,特别是在治疗心血管疾病的药物中的应用。